{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:18:36Z","timestamp":1764181116725,"version":"3.46.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Medical Science Advancement Program of Wuhan University","award":["TFLC 2018001"],"award-info":[{"award-number":["TFLC 2018001"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871419","82101548","U2267221"],"award-info":[{"award-number":["81871419","82101548","U2267221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Technologies Research and Development Program of China","award":["2018YFC1314600"],"award-info":[{"award-number":["2018YFC1314600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Neuromelanin is mostly located in dopaminergic neurons in the substantia nigra (SN) pars compacta, and can be detected by magnetic resonance imaging (MRI). It is a promising imaging-base biomarker for neurological diseases. We previously developed a melanin-specific probe N-(2-(diethylamino)-ethyl)-\n                      <jats:sup>18<\/jats:sup>\n                      F-5-fluoropicolinamide (\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA), which was initially developed for the imaging of melanoma.\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA exhibited high levels of binding to the melanin in vitro and in vivo with high retention and favorable pharmacokinetics. In this study we further investigated whether\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA could be used to quantitatively detect neuromelanin in the SN in healthy rhesus macaques.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA exhibited desired hydrophobicity with estimated log K ow 5.08 and log D7.4 1.68.\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA readily crossed the blood-brain barrier with brain transport coefficients (Kin) of 40\u2009\u00b1\u20098 \u00b5L g-1s-1.\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA accumulated specifically in neuromelanotic PC12 cells, melanin-rich melanoma cells, and melanoma xenografts.\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA binding was significantly higher in B16F10 cells vs. amelanotic SKOV3 cells (6.17\u2009\u00b1\u20090.53%IA vs. 0.24\u2009\u00b1\u20090.05%IA) and in pigmented PC12 cells vs. non-pigmented PC12 cells(7.09\u2009\u00b1\u20090.15%IA and 0.29\u2009\u00b1\u20090.05%IA).In the biodistribution study,\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA had higher accumulation in B16F10 tumors (6.31\u2009\u00b1\u20090.99%IA\/g) than in SKOV3 tumors (0.25\u2009\u00b1\u20090.09%IA\/g). Meanwhile,\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA uptake in B16F10 tumors could be blocked by excess cold\n                      <jats:sup>19<\/jats:sup>\n                      F-P3BZA (0.81\u2009\u00b1\u20090.02%IA\/g, 88% inhibition,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). PET\/MRI\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA provided clear visualization of neuromelanin-rich SN at 30\u201360\u00a0min after injection in healthy macaques. The SN to cerebella ratios were 2.7 and 2.4 times higher at 30 and 60\u00a0min after injection. In vitro autoradiography studies\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA exhibited high levels of binding to the SN of healthy human and almost no binding to the SN of Parkinson\u2019s disease patient.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-P3BZA PET\/MRI clearly images neuromelanin in the SN, and may assist in the early diagnosis of neurological diseases associated with abnormal neuromelanin expression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13550-025-01297-5","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:26:01Z","timestamp":1763983561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuromelanin-targeted 18F-P3BZA PET\/MR imaging of the substantia nigra in rhesus macaques"],"prefix":"10.1186","volume":"15","author":[{"given":"Hongyan","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"publisher","first-page":"17567","DOI":"10.1073\/pnas.0808768105","volume":"105","author":"L Zecca","year":"2008","unstructured":"Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, et al. New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci USA. 2008;105:17567\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR2","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0403495101","volume":"101","author":"L Zecca","year":"2004","unstructured":"Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia Nigra during aging. Proc Natl Acad Sci USA. 2004;101:9843\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12640-013-9435-y","volume":"25","author":"FA Zucca","year":"2014","unstructured":"Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, et al. Neuromelanin of the human substantia nigra: an update. Neurotox Res. 2014;25:13\u201323.","journal-title":"Neurotox Res"},{"key":"1297_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8:1150\u20137.","journal-title":"Lancet Neurol"},{"key":"1297_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.neubiorev.2021.10.028","volume":"132","author":"F Ueno","year":"2022","unstructured":"Ueno F, Iwata Y, Nakajima S, Caravaggio F, Rubio JM, Horga G, et al. Neuromelanin accumulation in patients with schizophrenia: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;132:1205\u201313.","journal-title":"Neurosci Biobehav Rev"},{"key":"1297_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, et al. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for parkinson\u2019s disease. NPJ Parkinsons Dis. 2018;4:11.","journal-title":"NPJ Parkinsons Dis"},{"key":"1297_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.007","volume":"58","author":"J Wang","year":"2019","unstructured":"Wang J, Huang Z, Li Y, Ye F, Wang C, Zhang Y, et al. Neuromelanin-sensitive MRI of the substantia nigra: an imaging biomarker to differentiate essential tremor from tremor-dominant parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;58:3\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1297_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.schres.2018.02.033","volume":"197","author":"M Tavares","year":"2018","unstructured":"Tavares M, Reimao S, Chendo I, Carvalho M, Levy P, Nunes RG. Neuromelanin magnetic resonance imaging of the substantia Nigra in first episode psychosis patients consumers of illicit substances. Schizophr Res. 2018;197:620\u20131.","journal-title":"Schizophr Res"},{"key":"1297_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12264-017-0202-6","volume":"34","author":"ZY Liu","year":"2018","unstructured":"Liu ZY, Liu FT, Zuo CT, Koprich JB, Wang J. Update on molecular imaging in parkinson\u2019s disease. Neurosci Bull. 2018;34:330\u201340.","journal-title":"Neurosci Bull"},{"key":"1297_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","volume":"17","author":"M Sasaki","year":"2006","unstructured":"Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia Nigra in parkinson\u2019s disease. NeuroReport. 2006;17:1215\u20138.","journal-title":"NeuroReport"},{"key":"1297_CR11","doi-asserted-by":"crossref","unstructured":"Mak E, Kouli A, Holland N, Nicastro N, Savulich G, Surendranathan A et al. [18F]-AV-1451 binding in the substantia Nigra as a marker of neuromelanin in lewy body diseases. Brain Commun. 2021;28:3.","DOI":"10.1093\/braincomms\/fcab177"},{"key":"1297_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/WCO.0000000000000584","volume":"31","author":"V Rispoli","year":"2018","unstructured":"Rispoli V, Schreglmann SR, Bhatia KP. Neuroimaging advances in parkinson\u2019s disease. Curr Opin Neurol. 2018;31:415\u201324.","journal-title":"Curr Opin Neurol"},{"key":"1297_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00429-017-1507-y","volume":"223","author":"S Coakeley","year":"2018","unstructured":"Coakeley S, Cho SS, Koshimori Y, Rusjan P, Ghadery C, Kim J, et al. [18F]AV-1451 binding to neuromelanin in the substantia Nigra in PD and PSP. Brain Struct Funct. 2018;223:589\u201395.","journal-title":"Brain Struct Funct"},{"key":"1297_CR14","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/brain\/aww098","volume":"139","author":"AK Hansen","year":"2016","unstructured":"Hansen AK, Knudsen K, Lillethorup TP, Landau AM, Parbo P, Fedorova T, et al. In vivo imaging of neuromelanin in parkinson\u2019s disease using 18F-AV-1451 PET. Brain. 2016;139:2039\u201349.","journal-title":"Brain"},{"key":"1297_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1148\/radiology.204.2.9240529","volume":"204","author":"WS Enochs","year":"1997","unstructured":"Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R. Paramagnetic metal scavenging by melanin: MR imaging. Radiology. 1997;204:417\u201323. https:\/\/doi.org\/10.1148\/radiology.204.2.9240529.","journal-title":"Radiology"},{"key":"1297_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2967\/jnumed.118.209643","volume":"60","author":"X Ma","year":"2019","unstructured":"Ma X, Wang S, Wang S, Liu D, Zhao X, Chen H, et al. Biodistribution, radiation dosimetry, and clinical application of a melanin-targeted PET probe, (18)F-P3BZA, in patients. J Nucl Med. 2019;60:16\u201322.","journal-title":"J Nucl Med"},{"key":"1297_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1021\/jm301740k","volume":"56","author":"H Liu","year":"2013","unstructured":"Liu H, Liu S, Miao Z, Deng Z, Shen B, Hong X, et al. Development of 18F-labeled Picolinamide probes for PET imaging of malignant melanoma. J Med Chem. 2013;56:895\u2013901.","journal-title":"J Med Chem"},{"key":"1297_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1148\/radiol.14132042","volume":"272","author":"L Bu","year":"2014","unstructured":"Bu L, Li R, Liu H, Feng W, Xiong X, Zhao H, et al. Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18FP3BZA PET\/CT. Radiology. 2014;272:174\u201383.","journal-title":"Radiology"},{"key":"1297_CR19","doi-asserted-by":"crossref","unstructured":"Hong Z, Yu B, Xiao J, Feng H, Ma X, Cheng Z et al. A convenient and efficient solid phase extraction-based pathway for purification of melanin-targeted probe 18F-P3BZA. Microchem J. 2021;168.","DOI":"10.1016\/j.microc.2021.106008"},{"key":"1297_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2967\/jnumed.119.234922","volume":"61","author":"A Wurzer","year":"2020","unstructured":"Wurzer A, Di Carlo D, Schmidt A, Beck R, Eiber M, Schwaiger M, et al. Radiohybrid ligands: a novel tracer concept exemplified by 18F- or 68Ga-labeled RhPSMA inhibitors. J Nucl Med. 2020;61:735\u201342.","journal-title":"J Nucl Med"},{"key":"1297_CR21","first-page":"209","volume":"89","author":"QR Smith","year":"2003","unstructured":"Smith QR, Allen DD. In situ brain perfusion technique. Methods Mol Med. 2003;89:209\u201318.","journal-title":"Methods Mol Med"},{"key":"1297_CR22","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1248\/bpb.30.2031","volume":"30","author":"M Ishikawa","year":"2007","unstructured":"Ishikawa M, Kawase I, Ishii F. Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo. Biol Pharm Bull. 2007;30:2031\u20136.","journal-title":"Biol Pharm Bull"},{"key":"1297_CR23","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","volume":"97","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci USA. 2000;97:11869\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR24","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/srep01490","volume":"3","author":"C Qin","year":"2013","unstructured":"Qin C, Cheng K, Chen K, Hu X, Liu Y, Lan X, et al. Tyrosinase as a multifunctional reporter gene for photoacoustic\/mri\/pet triple modality molecular imaging. Sci Rep. 2013;3:1490.","journal-title":"Sci Rep"},{"key":"1297_CR25","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.1021\/jm300371c","volume":"55","author":"ML James","year":"2012","unstructured":"James ML, Shen B, Zavaleta CL, Nielsen CH, Mesangeau C, Vuppala PK, et al. New positron emission tomography (PET) radioligand for imaging sigma-1 receptors in living subjects. J Med Chem. 2012;55:8272\u201382.","journal-title":"J Med Chem"},{"key":"1297_CR26","doi-asserted-by":"crossref","unstructured":"Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D et al. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse. 2009;63:871\u201380.","DOI":"10.1002\/syn.20670"},{"key":"1297_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/cns.12493","volume":"22","author":"J Zou","year":"2016","unstructured":"Zou J, Weng RH, Chen ZY, Wei XB, Wang R, Chen D, et al. Position emission tomography\/single-photon emission tomography neuroimaging for detection of premotor parkinson\u2019s disease. CNS Neurosci Ther. 2016;22:167\u201377.","journal-title":"CNS Neurosci Ther"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01297-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01297-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01297-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:13:47Z","timestamp":1764180827000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-025-01297-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01297-5","relation":{},"ISSN":["2191-219X"],"issn-type":[{"type":"electronic","value":"2191-219X"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the Institutional Animal Care and Use Committee of Renmin Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No other potential conflict of interest relevant to this article was reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}